Lovastatin Tablet
Product Images NDC 63187-194

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 63187-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure of Lovastatin shown as a 2D molecular diagram with labeled atoms and bonds depicting stereochemistry and functional groups.*

FDA Label Image

Table I (Lov00 0004 02)

Data table presenting the effect of various drugs or grapefruit juice coadministered with lovastatin on lovastatin exposure. It includes number of subjects, dosing information for both coadministered drug and lovastatin, and the AUC ratio comparing lovastatin exposure with and without the coadministered drug.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over six years of follow-up. Two lines compare Lovastatin with placebo, indicating a 37% risk reduction favoring Lovastatin with statistical significance (p < 0.001).*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Table VII Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' listing interacting agents such as strong CYP3A4 inhibitors, HIV protease inhibitors, Gemfibrozil, Cyclosporine, Danazol, Diltiazem, Dronedarone, Verapamil, Amiodarone, and grapefruit juice, along with prescribing recommendations regarding their use with lovastatin.*

FDA Label Image

63187-194-90 (Lov00 0005 05)

Lovastatin 10 mg tablet packaging label from Proficient Rx LP. The label shows the product name, strength, dosage form, and quantity (#30 tablets). Tablets are described as white to off-white, round, and unscored, engraved with 'CTI' over '141'. Manufacturer listed as Carlsbad Technology, Inc., with storage instructions and caution to keep out of reach of children. NDC 63187-194-30 is visible along with lot, expiration, and packaging details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.